Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Awards

- PMLiVE

ViiV and Janssen plan pivotal trials of monthly HIV treatment

Rilpivirine – cabotegravir combination could provide a monthly option

- PMLiVE

Up in smoke

The side-lining of efficacy in medical cannabis debates

- PMLiVE

Less is more: how risk-based monitoring is changing trials

A quality risk management approach is one of the biggest drivers for change in clinical research

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid Group Communications Limited

- PMLiVE

Getting patients to engage with clinical trials

The EUPATI European initiative and increasing public knowledge of research

Blue Latitude Health shortlisted for two PMEA 2015 awards

Blue Latitude Health’s Medical Information Cascade project for Eli Lilly and Company has been shortlisted in the Excellence in Physicians/Healthcare Provider Support Programmes and Innovation categories.

Blue Latitude Health

- PMLiVE

Harnessing clinical data

A greater focus on stakeholders could improve pharma's trial challenges

- PMLiVE

Get Real! The Rise of Observational Data In Healthcare

Real world data is now becoming a serious research tool for pharma, but just what can it add to the golden standard that is the randomised clinical trial?

- PMLiVE

Health wins big at second UK Blog Awards

Evidently Cochrane named Company Health Blog of the Year

- PMLiVE

WHO calls for publication of previously unreported studies

Organisation claims results from clinical trials should be reported within 12 months

- PMLiVE

Baxter haemophilia drug clears phase III trial

BAX 817 shown to resolve more than 90% of acute bleeds

Eli Lilly HQ

Lilly sets back evacetrapib data deadline

Cholesterol drug trials extended by six months

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links